(Q45296407)

11 December 2017

title

Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide (English)

1 reference

angioimmunoblastic T-cell lymphoma

11 December 2017

0 references

0 references

1 reference

Dogan A

1

1 reference

11 December 2017

Ngu LS

series ordinal

2

1 reference

11 December 2017

Ng SH

series ordinal

3

1 reference

11 December 2017

Cervi PL

series ordinal

4

1 reference

11 December 2017

publication date

1 May 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

19

1 reference

11 December 2017

issue

5

1 reference

11 December 2017

page(s)

873-875

1 reference

Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

Angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

7 January 2021

Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

7 January 2021

Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

7 January 2021

Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403710

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403710

1 reference

Dimensions Publication ID

11 December 2017

1049174466

0 references

1 reference